Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

NC woman is now insulin-free after series of three islet cell transplants

09.06.2005


Carolinas Medical Center is one of only 10 facilities nationwide offering this specialized procedure, which is still experimental but offers hope of dramatic lifestyle improvements for a huge number of Type 1 diabetics.



A Davidson woman has been successfully treated for her Type 1 diabetes through a procedure performed at Carolinas Medical Center. Paul F. Gores, M.D., has led a multi-disciplinary team through a series of three pancreatic islet cell transplants since the summer of 2003. The result is a patient who is now insulin-free. "This is a giant step for diabetes research, our transplant team, our patient, and all Type 1 diabetics," said Dr. Gores. "I can’t tell you how exciting it is to be a part of ground-breaking research that could one day change the quality of millions of lives."

Dr. Gores stresses that this procedure, while successful in this case, and an important step in the research that will eventually result in a cure for all insulin-dependent diabetics, is not a cure for everyone. Only a few medical centers in the world – ten in the United States – are currently offering this procedure, which is experimental and done as clinical research.


"A significant challenge remains the scarcity of organ donors," explained Dr. Gores. Also because patients must take immunosuppressive drugs to protect the transplanted tissue from being rejected, the procedure is only for a select group of patients with Type I diabetes. Immunosuppressive drugs have several potentially serious side effects and until a method is discovered that protects the islets and is free of dangerous side effects, the procedure will not be appropriate for the vast majority of diabetic patients.

Islets are cell clusters in the pancreas that determine the body’s need, and release the necessary amount of insulin to maintain normal blood sugar levels in the body. In Type 1 diabetes, the pancreas does not produce that insulin, forcing patients to inject insulin every day. Type 1 diabetes carries with it increased risks of kidney failure, nerve damage, heart disease, and blindness. "Daily insulin shots have been a part of my life for years," relates patient Andrea "Annie" Anderson. "I’m still getting used to life without finger pricks and needle sticks. I feel so fortunate to have received this procedure and for it to have been successful."

Before the transplant, islet cells are collected from a donor pancreas through a complex purification process. Physicians then insert a catheter into the patient’s abdomen, and using x-ray guidance, thread it into the portal vein, which carries blood to the liver. About a teaspoonful of islet cells are injected through the catheter. The cells disperse throughout the liver where it is intended that they will live and produce insulin. The patient is alert during the process but receives local anesthesia to numb the skin where the catheter is inserted. Most patients stay in the recovery area for a few hours, and are able to go home within a day or two. As in Annie’s case, more than one transfusion of islet cells may be needed.

"Islet transplantation has been in the experimental stage for more than 25 years," said Dr. Gores. "It’s considered a treatment rather than a cure, although in several recent studies, islet cell transplantation has been successful enough for some people with Type 1 diabetes to completely stop taking insulin injections. For Anderson this is a dream come true."

CMC’s islet cell transplant research is being funded by the National Institutes of Health.

The Transplant Center at Carolinas Medical Center in Charlotte has been active in transplantation since 1970 when the first kidney transplant was performed here. The program has grown steadily and today includes programs transplanting heart, liver, kidney and pancreas.

The islet transplant teams consist of surgeons, nephrologists (physicians specializing in kidney disease), transplant coordinators, scientists, social workers, dietitians and pharmacists. In 2004, the Transplant Center performed 83 kidney, 17 heart, 24 liver, and 5 kidney/pancreas transplants.

Raymond C. Jones | EurekAlert!
Further information:
http://www.carolinas.org

More articles from Life Sciences:

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Will Earth still exist 5 billion years from now?

08.12.2016 | Physics and Astronomy

Oxygen can wake up dormant bacteria for antibiotic attacks

08.12.2016 | Health and Medicine

Newly discovered bacteria-binding protein in the intestine

08.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>